US FDA Guidance on Using Bayesian Statistics in Medical Device Clinical Trials
This article was originally published in RAJ Devices
Roger Sewell and Elisabeth Crowe analyse the agency’s new guidance and explain how device sponsors can benefit from using the Bayesian approach.
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.